BTK Inhibition for Waldenstrom Macroglobulinemia

EP. 1: The Nature of Waldenstrom Macroglobulinemia

February 15th 2019

EP. 2: Risk Factors in Developing Waldenstrom Macroglobulinemia

February 15th 2019

EP. 3: Waldenstrom Macroglobulinemia: Establishing a Diagnosis

February 15th 2019

EP. 4: Factors Impacting a Diagnosis and Prognosis of WM

February 15th 2019

EP. 5: Waldenstrom Macroglobulinemia: When to Initiate Therapy

February 15th 2019

EP. 6: A Historic Perspective on Frontline WM Management

February 15th 2019

EP. 7: Waldenstrom Macroglobulinemia: Evolving Frontline Treatment

February 15th 2019

EP. 8: Selecting Therapy Through Multiple Lines in WM

February 15th 2019

EP. 9: Targeted Approaches in Waldenstrom Macroglobulinemia

February 15th 2019

EP. 10: BTK Inhibitors in WM: Understanding Safety/Efficacy

February 15th 2019

EP. 11: Future Management of Waldenstrom Macroglobulinemia

February 15th 2019